Circulating angiopoietin-2 levels increase with progress of chronic kidney disease

Angiopoietin 2 and Cardiovascular Disease in Dialysis and Kidney Transplantation

(2009) Sascha David et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?

(2009) Mahmut Ilker Yilmaz et al.   CLINICAL TRANSPLANTATION

Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome

(2009) Philipp Kümpers et al.   INTENSIVE CARE MEDICINE

Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin

(2009) Sascha David et al.   JOURNAL OF HYPERTENSION

Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement

(2009) P. Kumpers et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Angiopoietin‐2 levels as a biomarker of cardiovascular risk in patients with hypertension

(2008) Jeetesh V. Patel et al.   ANNALS OF MEDICINE

Balance between Angiopoietin-1 and Angiopoietin-2 Is in Favor of Angiopoietin-2 in Atherosclerotic Plaques with High Microvessel Density

(2008) Simone Post et al.   JOURNAL OF VASCULAR RESEARCH

Two Cardiovascular Risk Factors in One? Homocysteine and Its Relation to Glomerular Filtration Rate

(2008) Jan T. Kielstein et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients

(2007) K. Caglar et al.   Clinical Journal of the American Society of Nephrology